Suhan Ni

Array ( [id] => 211680 [patent_doc_number] => 07622586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Opiate intermediates and methods of synthesis' [patent_app_type] => utility [patent_app_number] => 11/741932 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5793 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622586.pdf [firstpage_image] =>[orig_patent_app_number] => 11741932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247917 [patent_doc_number] => 20070244151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Opiate Intermediates and Methods of Synthesis' [patent_app_type] => utility [patent_app_number] => 11/741910 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5794 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244151.pdf [firstpage_image] =>[orig_patent_app_number] => 11741910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688826 [patent_doc_number] => 20080033007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Substituted Tetrahydroisoquinoline Compounds for Cancer Therapy' [patent_app_type] => utility [patent_app_number] => 11/737126 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21273 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033007.pdf [firstpage_image] =>[orig_patent_app_number] => 11737126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5011469 [patent_doc_number] => 20070281948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'SUBSTITUTED 2-PYRIDONE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENT' [patent_app_type] => utility [patent_app_number] => 11/733833 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11042 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281948.pdf [firstpage_image] =>[orig_patent_app_number] => 11733833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4910267 [patent_doc_number] => 20080021034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Compositions and methods for modulating gated ion channels' [patent_app_type] => utility [patent_app_number] => 11/786420 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25464 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021034.pdf [firstpage_image] =>[orig_patent_app_number] => 11786420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586013 [patent_doc_number] => 20090105215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Heterocyclic compounds, methods for the preparation thereof, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/783193 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41764 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105215.pdf [firstpage_image] =>[orig_patent_app_number] => 11783193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485846 [patent_doc_number] => 20090275611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Compounds Which Modulate The CB2 Receptor' [patent_app_type] => utility [patent_app_number] => 12/293484 [patent_app_country] => US [patent_app_date] => 2007-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9504 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275611.pdf [firstpage_image] =>[orig_patent_app_number] => 12293484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104053 [patent_doc_number] => 08153674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Organic compounds' [patent_app_type] => utility [patent_app_number] => 12/295155 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41216 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153674.pdf [firstpage_image] =>[orig_patent_app_number] => 12295155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691398 [patent_doc_number] => 20070232635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/728672 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17868 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232635.pdf [firstpage_image] =>[orig_patent_app_number] => 11728672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113630 [patent_doc_number] => 20070197546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'QUINOLINE-4-CARBOXAMIDE AS NK-2 AND NK-3 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/691899 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15882 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197546.pdf [firstpage_image] =>[orig_patent_app_number] => 11691899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693119 [patent_doc_number] => 20080085890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/728897 [patent_app_country] => US [patent_app_date] => 2007-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 186826 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085890.pdf [firstpage_image] =>[orig_patent_app_number] => 11728897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046616 [patent_doc_number] => 20070265290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Heterocyclic selective androgen receptor modulators and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/723957 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15939 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265290.pdf [firstpage_image] =>[orig_patent_app_number] => 11723957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070226 [patent_doc_number] => 20070191328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Isoquinoline compounds' [patent_app_type] => utility [patent_app_number] => 11/725855 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8922 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191328.pdf [firstpage_image] =>[orig_patent_app_number] => 11725855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 574897 [patent_doc_number] => 07459465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Isoquinoline compound and pharmaceutical use thereof' [patent_app_type] => utility [patent_app_number] => 11/688103 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24856 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459465.pdf [firstpage_image] =>[orig_patent_app_number] => 11688103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4415 [patent_doc_number] => 07816371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Bicycloheteroaryl compounds as P2X7 modulators and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/725153 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47122 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816371.pdf [firstpage_image] =>[orig_patent_app_number] => 11725153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220367 [patent_doc_number] => 20070161678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Methods for the synthesis of pyridoxamine' [patent_app_type] => utility [patent_app_number] => 11/725094 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14982 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161678.pdf [firstpage_image] =>[orig_patent_app_number] => 11725094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4573102 [patent_doc_number] => 07829584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Pyridines and pyridine N-oxides as modulators of thrombin' [patent_app_type] => utility [patent_app_number] => 11/685544 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23796 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829584.pdf [firstpage_image] =>[orig_patent_app_number] => 11685544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220360 [patent_doc_number] => 20070161671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => '7-Azaindoles and the use thereof as therapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/714466 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8649 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161671.pdf [firstpage_image] =>[orig_patent_app_number] => 11714466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441878 [patent_doc_number] => 20090093517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'BIS1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES AND THEIR USES AS PHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 12/282968 [patent_app_country] => US [patent_app_date] => 2007-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15693 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093517.pdf [firstpage_image] =>[orig_patent_app_number] => 12282968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317622 [patent_doc_number] => 08232399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Chiral ligands, their preparation and uses thereof in asymmetric reactions' [patent_app_type] => utility [patent_app_number] => 12/281267 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11561 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12281267 [rel_patent_id] =>[rel_patent_doc_number] =>)